Literature DB >> 13306851

Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.

P GERBER, D HAMRE, C G LOOSLI.   

Abstract

Four successive generations of antigenic variants of influenza PR8-S virus, each derived from the previous one by serial passage in the lungs of mice immunized with the homologous agent, were compared with the original parent PR8-S virus with respect to their serological and immunological character. It was demonstrated by means of H.I., complement-fixation and in ovo-neutralization tests that the variants exhibited a progressively decreasing reactivity with the parent PR8-S antiserum while retaining the ability to elicit antibody to PR8-S influenza virus and to their respective predecessors. Accompanying these changes was a progressive reduction in antigenicity without any significant changes in pathogenicity for mice. Experimental evidence was presented which indicates that the serological changes observed with the variants are not related to the P-Q phenomenon. Antibody absorption tests showed that the variants share antigens with PR8-S virus but differ from it by the presence of specific antigenic components; these increase in quantity with each successive variant while the amount of related antigens shows a progressive decrease. The importance of evaluating the significance of antigenic changes of influenza viruses with active immunity tests was emphasized by the fact that PR8-S vaccine protected mice against fatal infection with lethal doses of the variant strains although the latter had a progressively decreasing serological reactivity with PR8-S antiserum. The inheritable character of the new antigenic properties of the variant strains was demonstrated by their persistence in the absence of thea selective environment following 18 to 24 serial intranasal passages with large inocula in normal mice and following limiting dilution passage in fertile eggs.

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; INFLUENZA VIRUSES/immunology

Mesh:

Substances:

Year:  1956        PMID: 13306851      PMCID: PMC2180354          DOI: 10.1084/jem.103.4.413

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  A procedure which eliminates nonspecific inhibitor from human serum but does not affect specific antibodies against influenza viruses.

Authors:  D A J TYRRELL; F L HORSFALL
Journal:  J Immunol       Date:  1952-11       Impact factor: 5.422

2.  Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1.

Authors:  A ISAACS; A W GLEDHILL; C H ANDREWES
Journal:  Bull World Health Organ       Date:  1952       Impact factor: 9.408

3.  Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition.

Authors:  M R HILLEMAN; F L HORSFALL
Journal:  J Immunol       Date:  1952-09       Impact factor: 5.422

4.  Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report.

Authors:  T Francis; J E Salk; J J Quilligan
Journal:  Am J Public Health Nations Health       Date:  1947-08

5.  THE LETHAL EFFECT OF TRIETHYLENE GLYCOL VAPOR ON AIR-BORNE BACTERIA AND INFLUENZA VIRUS.

Authors:  O H Robertson; T T Puck; H F Lemon; C G Loosli
Journal:  Science       Date:  1943-02-05       Impact factor: 47.728

6.  Serological behaviour of influenza viruses. II. Patterns of antigenic relationship.

Authors:  P FISET; R DEPOUX
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

7.  Epidemic influenza B and C in navy recruits, 1953-1954. I. Antigenic studies on influenza virus, type B.

Authors:  R L WOOLRIDGE; J L DEMEIO; J E WHITESIDE; J R SEAL
Journal:  Proc Soc Exp Biol Med       Date:  1955-03

8.  STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B.

Authors:  M Wiener; W Henle; G Henle
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307

9.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

10.  Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.

Authors:  D L WALKER; F L HORSFALL
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more
  11 in total

1.  [Influenza vaccine cultivation].

Authors:  W O GROSS
Journal:  Arch Gesamte Virusforsch       Date:  1959

2.  [Accelerated serum adaptation of the influenza virus due to raised variation rate after roentgen irradiation].

Authors:  W O GROSS; I SCHMEHL
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  On the antigenic variation of the influenza A virus.

Authors:  G TAKATSY; J FURESZ
Journal:  Arch Gesamte Virusforsch       Date:  1957

4.  [International conference on influenza in HONG KONG].

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  General discussion-Session V.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

6.  The impact of host immune status on the within-host and population dynamics of antigenic immune escape.

Authors:  Shishi Luo; Michael Reed; Jonathan C Mattingly; Katia Koelle
Journal:  J R Soc Interface       Date:  2012-05-09       Impact factor: 4.118

7.  Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.

Authors:  D HAMRE; C G LOOSLI; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

8.  Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine.

Authors:  D HAMRE; C G LOOSLI; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

9.  Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

Authors:  W Gerhard; R G Webster
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.

Authors:  Kari Debbink; John T McCrone; Joshua G Petrie; Rachel Truscon; Emileigh Johnson; Emily K Mantlo; Arnold S Monto; Adam S Lauring
Journal:  PLoS Pathog       Date:  2017-01-31       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.